{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T12:04:40Z","timestamp":1770984280695,"version":"3.50.1"},"reference-count":66,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.drugalcdep.2012.07.002","type":"journal-article","created":{"date-parts":[[2012,7,25]],"date-time":"2012-07-25T06:04:58Z","timestamp":1343196298000},"page":"207-214","source":"Crossref","is-referenced-by-count":25,"title":["Twelve-year trend in treatment seeking for buprenorphine abuse in Finland"],"prefix":"10.1016","volume":"127","author":[{"given":"Hanna","family":"Uosukainen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jussi","family":"Kauhanen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sari","family":"Voutilainen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaana","family":"F\u00f6hr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mika","family":"Paasolainen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jari","family":"Tiihonen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirsti","family":"Laitinen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ifeoma N.","family":"Onyeka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Simon","family":"Bell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2012.07.002_bib0005","doi-asserted-by":"crossref","first-page":"250","DOI":"10.4103\/0019-5545.70978","article-title":"Pattern of buprenorphine abuse among opioid abusers in Nepal","volume":"52","author":"Aich","year":"2010","journal-title":"Indian J. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2012.07.002_bib0010","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.drugalcdep.2006.09.012","article-title":"Abuse liability of buprenorphine-naloxone tablets in untreated IV drug users","volume":"88","author":"Alho","year":"2007","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2012.07.002_bib0015","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1046\/j.1360-0443.2000.95913637.x","article-title":"A longitudinal study of male buprenorphine addicts attending an addiction clinic in India","volume":"95","author":"Basu","year":"2000","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2012.07.002_bib0020","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/ADM.0b013e3182034e31","article-title":"Illicit use of buprenorphine\/naloxone among injecting and noninjecting opioid users","volume":"5","author":"Bazazi","year":"2011","journal-title":"J. Addict. Med."},{"key":"10.1016\/j.drugalcdep.2012.07.002_bib0025","series-title":"European Addiction Severity Index (EuropASI). A Guide to Training and Administering EuropASI Interviews","author":"Blacken","year":"1994"},{"key":"10.1016\/j.drugalcdep.2012.07.002_bib0030","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1001\/jama.2011.370","article-title":"Association between opioid prescribing patterns and opioid overdose-related deaths","volume":"305","author":"Bohnert","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.drugalcdep.2012.07.002_bib0035","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.drugalcdep.2003.10.012","article-title":"Prescription opioid abuse in patients presenting for methadone maintenance treatment","volume":"73","author":"Brands","year":"2004","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2012.07.002_bib0040","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0306-4603(03)00082-0","article-title":"Methamphetamine use behaviors and gender differences","volume":"29","author":"Brecht","year":"2004","journal-title":"Addict. Behav."},{"key":"10.1016\/j.drugalcdep.2012.07.002_bib0045","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1080\/00952990802585406","article-title":"Lack of reduction in buprenorphine injection after introduction of co-formulated buprenorphine\/naloxone to the Malaysian market","volume":"35","author":"Bruce","year":"2009","journal-title":"Am. J. Drug Alcohol Abuse"},{"key":"10.1016\/j.drugalcdep.2012.07.002_bib0050","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1111\/j.1360-0443.1990.tb01612.x","article-title":"Buprenorphine abuse: report from India","volume":"85","author":"Chowdhury","year":"1990","journal-title":"Br. J. Addict."},{"key":"10.1016\/j.drugalcdep.2012.07.002_bib0055","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.jpain.2005.05.004","article-title":"Trends in abuse of Oxycontin and other opioid analgesics in the United States: 2002\u20132004","volume":"6","author":"Cicero","year":"2005","journal-title":"J. Pain"},{"key":"10.1016\/j.drugalcdep.2012.07.002_bib0060","doi-asserted-by":"crossref","first-page":"302","DOI":"10.5055\/jom.2007.0018","article-title":"Use and misuse of buprenorphine in the management of opioid addiction","volume":"3","author":"Cicero","year":"2007","journal-title":"J. Opioid Manag."},{"key":"10.1016\/j.drugalcdep.2012.07.002_bib0065","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.amepre.2010.01.022","article-title":"Hospitalizations for poisoning by prescription opioids, sedatives, and tranquilizers","volume":"38","author":"Coben","year":"2010","journal-title":"Am. J. Prev. Med."},{"key":"10.1016\/j.drugalcdep.2012.07.002_bib0070","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.drugalcdep.2005.05.009","article-title":"Major increases in opioid analgesic abuse in the United States: concerns and strategies","volume":"81","author":"Compton","year":"2006","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2012.07.002_bib0075","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.drugalcdep.2011.09.029","article-title":"Illicit use of buprenorphine in a community sample of young adult non-medical users of pharmaceutical opioids","volume":"122","author":"Daniulaityte","year":"2011","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2012.07.002_bib0080","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0376-8716(98)00028-3","article-title":"Self-report among injecting drug users: a review","volume":"51","author":"Darke","year":"1998","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2012.07.002_bib0085","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0376-8716(95)01171-9","article-title":"Levels and correlates of polydrug use among heroin users and regular amphetamine users","volume":"39","author":"Darke","year":"1995","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2012.07.002_bib0090","series-title":"Benefits and Risks of Pharmaceutical Opioids: Essential Treatment and Diverted Medication. A Global Review of Availability, Extra-Medical Use, Injection and the Association with HIV","author":"Degenhardt","year":"2008"},{"key":"10.1016\/j.drugalcdep.2012.07.002_bib0095","doi-asserted-by":"crossref","first-page":"161","DOI":"10.5694\/j.1326-5377.2009.tb02729.x","article-title":"Injection of medications used in opioid substitution treatment in Australia after the introduction of a mixed partial agonist-antagonist formulation","volume":"191","author":"Degenhardt","year":"2009","journal-title":"Med. J. Aust."},{"key":"10.1016\/j.drugalcdep.2012.07.002_bib0100","unstructured":"European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), 2000. Treatment Demand Indicator, Standard Protocol 2.0. EMCDDA Scientific Report, Lisbon."},{"key":"10.1016\/j.drugalcdep.2012.07.002_bib0105","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1080\/09595230801956124","article-title":"Comparing heroin users and prescription opioid users in a Canadian multi-site population of illicit opioid users","volume":"27","author":"Fischer","year":"2008","journal-title":"Drug Alcohol Rev."},{"key":"10.1016\/j.drugalcdep.2012.07.002_bib0110","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1503\/cmaj.060729","article-title":"Changes in illicit opioid use across Canada","volume":"175","author":"Fischer","year":"2006","journal-title":"CMAJ"},{"key":"10.1016\/j.drugalcdep.2012.07.002_bib0115","unstructured":"Forsell, M., Virtanen, A., J\u00e4\u00e4skel\u00e4inen, M., Alho, H., Partanen, A., 2010. Drug Situation in Finland 2010. National report to the EMCDDA by the Finnish National Focal Point, National Institute for Health and Welfare (THL), Report 39\/2010."},{"key":"10.1016\/j.drugalcdep.2012.07.002_bib0120","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1111\/j.1360-0443.1992.tb02660.x","article-title":"Severity of dependence and route of administration of heroin, cocaine and amphetamines","volume":"87","author":"Gossop","year":"1992","journal-title":"Br. J. Addict."},{"key":"10.1016\/j.drugalcdep.2012.07.002_bib0125","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1159\/000104883","article-title":"Buprenorphine misuse among heroin and amphetamine users in Malmo, Sweden: purpose of misuse and route of administration","volume":"13","author":"Hakansson","year":"2007","journal-title":"Eur. Addict. Res."},{"key":"10.1016\/j.drugalcdep.2012.07.002_bib0130","first-page":"143","article-title":"Korvaushoidon l\u00e4pimurto Suomessa (the breakthrough of Finnish substitution treatment)","volume":"70","author":"Hakkarainen","year":"2005","journal-title":"Yhteiskuntapolitiikka"},{"key":"10.1016\/j.drugalcdep.2012.07.002_bib0135","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s00228-011-1122-4","article-title":"Benzodiazepines and alcohol are associated with cases of fatal buprenorphine poisoning","volume":"68","author":"H\u00e4kkinen","year":"2012","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2012.07.002_bib0140","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1001\/archpsyc.1978.01770280111012","article-title":"Human pharmacology and abuse potential of the analgesic buprenorphine: a potential agent for treating narcotic addiction","volume":"35","author":"Jasinski","year":"1978","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2012.07.002_bib0145","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.drugalcdep.2011.07.019","article-title":"Diversion and abuse of buprenorphine: findings from national surveys of treatment patients and physicians","volume":"120","author":"Johanson","year":"2012","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2012.07.002_bib0150","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0376-8716(99)00102-7","article-title":"A comparison of the harms associated with the injection of heroin and amphetamines","volume":"58","author":"Kaye","year":"2000","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2012.07.002_bib0155","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0955-3959(99)00057-2","article-title":"Rapid assessment and response to injecting drug use in Madras, south India","volume":"11","author":"Kumar","year":"2000","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2012.07.002_bib0160","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.drugpo.2011.05.014","article-title":"Initiation into prescription opioid misuse amongst young injection drug users","volume":"23","author":"Lankenau","year":"2012","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2012.07.002_bib0165","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1465-3362.2011.00304.x","article-title":"The availability, diversion and injection of pharmaceutical opioids in South Asia","volume":"30","author":"Larance","year":"2011","journal-title":"Drug Alcohol Rev."},{"key":"10.1016\/j.drugalcdep.2012.07.002_bib0170","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.drugalcdep.2011.04.002","article-title":"Post-marketing surveillance of buprenorphine-naloxone in Australia: diversion, injection and adherence with supervised dosing","volume":"118","author":"Larance","year":"2011","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2012.07.002_bib0175","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1300\/J069v10n03_02","article-title":"The use of buprenorphine and temazepam by drug injectors","volume":"10","author":"Lavelle","year":"1991","journal-title":"J. Addict. Dis."},{"key":"10.1016\/j.drugalcdep.2012.07.002_bib0180","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0022-3565(25)30536-7","article-title":"The effects of morphine- and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog","volume":"197","author":"Martin","year":"1976","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drugalcdep.2012.07.002_bib0185","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/00005053-198001000-00006","article-title":"An improved diagnostic evaluation instrument for substance abuse patients. The Addiction Severity Index","volume":"168","author":"McLellan","year":"1980","journal-title":"J. Nerv. Ment. Dis."},{"key":"10.1016\/j.drugalcdep.2012.07.002_bib0190","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s11606-007-0129-0","article-title":"Primary care office-based buprenorphine treatment: comparison of heroin and prescription opioid dependent patients","volume":"22","author":"Moore","year":"2007","journal-title":"J. Gen. Intern. Med."},{"issue":"Suppl. 1","key":"10.1016\/j.drugalcdep.2012.07.002_bib0195","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.2165\/11536020-000000000-00000","article-title":"Intravenous misuse of buprenorphine: characteristics and extent among patients undergoing drug maintenance therapy","volume":"30","author":"Moratti","year":"2010","journal-title":"Clin. Drug Investig."},{"key":"10.1016\/j.drugalcdep.2012.07.002_bib0200","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.addbeh.2009.12.006","article-title":"The reliability and validity of drug users\u2019 self reports of amphetamine use among primarily heroin and cocaine users","volume":"35","author":"Napper","year":"2010","journal-title":"Addict. Behav."},{"key":"10.1016\/j.drugalcdep.2012.07.002_bib0205","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1465-3362.2011.00302.x","article-title":"Pharmaceutical opioid analgesic and heroin dependence: how do treatment-seeking clients differ in Australia?","volume":"30","author":"Nielsen","year":"2011","journal-title":"Drug Alcohol Rev."},{"key":"10.1016\/j.drugalcdep.2012.07.002_bib0210","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/j.1360-0443.2006.01731.x","article-title":"Concurrent buprenorphine and benzodiazepines use and self-reported opioid toxicity in opioid substitution treatment","volume":"102","author":"Nielsen","year":"2007","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2012.07.002_bib0215","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1111\/j.1360-0443.1988.tb00536.x","article-title":"Buprenorphine abuse among opiate addicts","volume":"83","author":"O\u2019Connor","year":"1988","journal-title":"Br. J. Addict."},{"key":"10.1016\/j.drugalcdep.2012.07.002_bib0220","unstructured":"Office of Applied Studies (OAS), 2010. Treatment Episode Data Set (TEDS) 1998\u20132008: National Admissions to Substance Abuse Treatment Services. DASIS Series: S-50. HHS Publication No. (SMA) 09-4471, Rockville, MD. Substance Abuse and Mental Health Services Administration."},{"key":"10.1016\/j.drugalcdep.2012.07.002_bib0225","series-title":"Epidemic: Responding to America's Prescription Drug Abuse Crisis","author":"Office of National Drug Control Policy","year":"2011"},{"key":"10.1016\/j.drugalcdep.2012.07.002_bib0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000253858","article-title":"Why do the clients of Georgian needle exchange programmes inject buprenorphine?","volume":"16","author":"Otiashvili","year":"2010","journal-title":"Eur. Addict. Res."},{"key":"10.1016\/j.drugalcdep.2012.07.002_bib0235","first-page":"3605","article-title":"Buprenorfiinin pist\u00e4minen yleistynyt huumeiden sekak\u00e4yt\u00f6ss\u00e4","volume":"59","author":"Partanen","year":"2004","journal-title":"Finn. Med. J."},{"key":"10.1016\/j.drugalcdep.2012.07.002_bib0240","first-page":"553","article-title":"Amfetamiinien ja opiaattien ongelmak\u00e4yt\u00f6n yleisyys Suomessa 2005","volume":"72","author":"Partanen","year":"2007","journal-title":"Yhteiskuntapolitiikka"},{"key":"10.1016\/j.drugalcdep.2012.07.002_bib0245","first-page":"534","article-title":"Amfetamiinien ja opiaattien k\u00e4yt\u00f6n yleisyys Suomessa 1998","volume":"65","author":"Partanen","year":"2000","journal-title":"Yhteiskuntapolitiikka"},{"key":"10.1016\/j.drugalcdep.2012.07.002_bib0250","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0376-8716(93)90036-P","article-title":"The misuse of buprenorphine and a buprenorphine-naloxone combination in Wellington New Zealand","volume":"33","author":"Robinson","year":"1993","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2012.07.002_bib0255","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.drugalcdep.2007.02.012","article-title":"Prescription opioid abuse among enrollees into methadone maintenance treatment","volume":"90","author":"Rosenblum","year":"2007","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2012.07.002_bib0260","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.drugalcdep.2008.03.025","article-title":"Buprenorphine in primary care: risk factors for treatment injection and implications for clinical management","volume":"97","author":"Roux","year":"2008","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2012.07.002_bib0265","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jsat.2010.03.014","article-title":"Self-treatment: illicit buprenorphine use by opioid-dependent treatment seekers","volume":"39","author":"Schuman-Olivier","year":"2010","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2012.07.002_bib0270","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1080\/10550490600625624","article-title":"Characterizing the emerging population of prescription opioid abusers","volume":"15","author":"Sigmon","year":"2006","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.drugalcdep.2012.07.002_bib0275","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1159\/000018994","article-title":"The EMCDDA\/Pompidou Group treatment demand indicator protocol: a European core item set for treatment monitoring and reporting","volume":"5","author":"Simon","year":"1999","journal-title":"Eur. Addict. Res."},{"key":"10.1016\/j.drugalcdep.2012.07.002_bib0280","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1300\/J069v21n01_04","article-title":"A comparison of patterns of methamphetamine and cocaine use","volume":"21","author":"Simon","year":"2002","journal-title":"J. Addict. Dis."},{"key":"10.1016\/j.drugalcdep.2012.07.002_bib0285","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.drugalcdep.2008.10.015","article-title":"Clinical characteristics of treatment-seeking prescription opioid vs. heroin-using adolescents with opioid use disorder","volume":"101","author":"Subramaniam","year":"2009","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2012.07.002_bib0290","unstructured":"Substance Abuse and Mental Health Services Administration, 2009. Results from the 2008 National Survey on Drug Use and Health: National Findings (Office of Applied Studies, NSDUH Series H-36, HHS Publication no SMA 09-4434, Table G2), Rockville, MD."},{"key":"10.1016\/j.drugalcdep.2012.07.002_bib0295","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.drugpo.2009.02.007","article-title":"HIV infection and risk behaviour of primary fentanyl and amphetamine injectors in Tallinn Estonia: implications for intervention","volume":"21","author":"Talu","year":"2010","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2012.07.002_bib0300","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.drugalcdep.2010.03.014","article-title":"Injection of buprenorphine and buprenorphine\/naloxone tablets in Malaysia","volume":"111","author":"Vicknasingam","year":"2010","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2012.07.002_bib0305","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0376-8716(02)00312-5","article-title":"Intravenous use of prescribed sublingual buprenorphine tablets by drug users receiving maintenance therapy in France","volume":"69","author":"Vidal-Trecan","year":"2003","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2012.07.002_bib0310","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/clpt.1994.71","article-title":"Clinical pharmacology of buprenorphine: ceiling effects at high doses","volume":"55","author":"Walsh","year":"1994","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.drugalcdep.2012.07.002_bib0315","doi-asserted-by":"crossref","first-page":"451","DOI":"10.47102\/annals-acadmedsg.V35N7p451","article-title":"Socio-demographic profile and help-seeking behaviour of buprenorphine abusers in Singapore","volume":"35","author":"Winslow","year":"2006","journal-title":"Ann. Acad. Med. Singapore"},{"key":"10.1016\/j.drugalcdep.2012.07.002_bib0320","series-title":"Lexicon of Alcohol and Drug Terms","author":"World Health Organization","year":"2012"},{"key":"10.1016\/j.drugalcdep.2012.07.002_bib0325","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2147\/SAR.S18969","article-title":"Differences in onset and abuse\/dependence episodes between prescription opioids and heroin: results from the National Epidemiologic Survey on Alcohol and Related Conditions","volume":"2011","author":"Wu","year":"2011","journal-title":"Subst. Abuse Rehabil."},{"key":"10.1016\/j.drugalcdep.2012.07.002_bib0330","doi-asserted-by":"crossref","first-page":"28","DOI":"10.2174\/1874473711104010028","article-title":"Buprenorphine and buprenorphine\/naloxone diversion, misuse, and illicit use: an international review","volume":"4","author":"Yokell","year":"2011","journal-title":"Curr. Drug Abuse Rev."}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871612002761?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871612002761?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T10:17:21Z","timestamp":1743848241000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871612002761"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":66,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S0376871612002761"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2012.07.002","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}